Search Results 771-780 of 17634 for protein intake optimization

1. Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... Specific laboratory requirements for Step 2 must be obtained within 2 weeks prior to Step 2 randomization.

2. Sam T. Savitz, Ph.D. - Mayo Clinic Faculty Profiles

   ... optimized. Dr. Savitz primarily uses administrative claims data and electronic health records to evaluate interventional and noninterventional therapies to ...

3. Clinical trials - Oncology (Medical)

   In general terms, scientists will study the cells, DNA, RNA, and proteins found in the tumor tissue and/or the blood to understand more about cancer and the ...

4. Genetically Engineered Cells (MUC1-Activated T-Cells) for the Treatment of MUC1 Positive Recurrent or Refractory Multiple Myeloma - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... Note: Patients with IgA myeloma in whom serum protein ... This requirement can be met in several different ways ...

5. Clinical trials - Oncology (Medical)

   Cohort 1 includes blood collections for in vitro studies which are a component of NIH-funded Project 3 within the Mayo Clinic Pancreatic SPORE, “Optimal ...

6. Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... generation sequencing or absence of MTAP protein in a tumor detected by IHC. ... requirements 3 ...

7. Physician Health Center - Core elements - Mayo Clinic

   To optimize the care of their medical condition(s) and their ability to ... Students · Admissions Requirements · Degree Programs · Student & Faculty Portal ...

8. Pharmacogenomics and Post-Operative Nausea and Vomiting - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...

9. Diet in Altering Disease Progression in Patients with Prostate Cancer on Active Surveillance - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...

10. A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later ... Measurable disease at Screening as defined by any of the following: Serum monoclonal paraprotein (M-protein) ...